Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 8/20 | 0.49 |
| ▸ | NPY4R | P50391 | 8/20 | 0.49 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.49 |
| ▸ | NPY1R | P25929 | 6/20 | 0.49 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.46 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.46 |
| ▸ | TFPI | P10646 | 3/20 | 0.45 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | RAMP3 | O60896 | 2/20 | 0.43 |
| ▸ | CALCR | P30988 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31670638 | 0.93 | NPY2R (0.51) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL30063854 | 0.89 | EPHA2 (0.57) | NPY2RNPY4RNPY5RNPY1REPHA2 | |
| SCHEMBL31665979 | 0.88 | EPHA2 (0.47) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL30062950 | 0.88 | C5AR1 (0.56) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL29679064 | 0.87 | NPY2R (0.49) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL29679071 | 0.87 | NPY2R (0.49) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL31031494 | 0.85 | CXCR4 (0.49) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL30062944 | 0.84 | EPHA2 (0.47) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL30064441 | 0.84 | F2 (0.41) | C5AR1 | |
| SCHEMBL30996221 | 0.84 | NPY2R (0.53) | NPY2RNPY4RNPY5RNPY1REPHA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3197912-B1 | LIPIDATED AMIDE-BASED INSULIN PRODRUGS | UNIV INDIANA RES & TECH CORP (US) | 2023-01-04 | — | — | EP | disclosed |